Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

Nature Reviews Immunology

Volumn 9, Issue 1, 2009, Pages 62-70

  Perretti, Mauro ^a   D'Acquisto, Fulvio ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN A1 RECEPTOR; BECLOMETASONE; BUDESONIDE; CORTICOSTERONE; HYDROCORTISONE; LIPOCORTIN 1; METHYLPREDNISOLONE ACETATE; MOMETASONE FUROATE; PREDNISOLONE; RECEPTOR PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ASTHMA; AUTOIMMUNE DISEASE; ECZEMA; GENE EXPRESSION REGULATION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; CIRCADIAN RHYTHM; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; IMMUNE SYSTEM; IMMUNITY, INNATE; INFLAMMATION; LIPOXINS; MACROPHAGES; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; MONOCYTES; NEUTROPHILS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; T-LYMPHOCYTE SUBSETS;

EID: 58149094363     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2470     Document Type: Review

References (84)

1. Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nature Immunol. 6, 1191-1197 (2005).
2. Serhan, C. N. et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332 (2007).
3. Gonzalez-Rey, E., Chorny, A. & Delgado, M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nature Rev. Immunol. 7, 52-63 (2007).
4. Rhen, T. & Cidlowski, J. A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 353, 1711-1723 (2005).
5. Sapolsky, R. M., Romero, L. M. & Munck, A. U. How do glucocorticoids influence stress responses-Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21, 55-89 (2000).
6. Parente, L. & Solito, E. Annexin 1: more than an antiphospholipase protein. Inflamm. Res. 53, 125-132 (2004).
7. 2+ signalling to membrane dynamics. Nature Rev. Mol. Cell Biol. 6, 449-461 (2005).
8. Morand, E. F. et al. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin. Immunol. Immunopathol. 76, 195-202 (1995).
9. Perretti, M. et al. Annexin I is stored within gelatinase granules of human neutrophils and mobilised on the cell surface upon adhesion but not phagocytosis. Cell Biol. Int. 24, 163-174 (2000).
10. Mulla, A., Leroux, C., Solito, E. & Buckingham, J. C. Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J. Clin. Endocrinol. Metab. 90, 557-562 (2005).
11. Perretti, M. et al. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nature Med. 22, 1259-1262 (1996).
12. Wein, S. et al. Mediation of annexin 1 secretion by a probenecid-sensitive ABC-transporter in rat inflamed mucosa. Biochem. Pharmacol. 67, 1195-1202 (2004).
13. Solito, E. et al. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J. 20, 1498-1500 (2006).
14. Lominadze, G. et al. Proteomic analysis of human neutrophil granules. Mol. Cell. Proteomics 4, 1503-1521 (2005).
15. Vong, L. et al. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J. Biol. Chem. 282, 29998-30004 (2007).
16. Rosengarth, A. & Luecke, H. A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J. Mol. Biol. 326, 1317-1325 (2003).
17. Perretti, M. & Flower, R. J. Annexin 1 and the biology of the neutrophil. J. Leukoc. Biol. 75, 25-29 (2004).
18. Lim, L. H. & Pervaiz, S. Annexin 1: the new face of an old molecule. FASEB J. 21, 968-975 (2007).
19. Lim, L. H., Solito, E., Russo-Marie, F., Flower, R. J. & Perretti, M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc. Natl Acad. Sci. USA 95, 14535-14539 (1998).
20. Walther, A., Riehemann, K. & Gerke, V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5, 831-840 (2000).
21. Zouki, C., Ouellet, S. & Filep, J. G. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. FASEB J. 14, 572-580 (2000).
22. Hayhoe, R. P. et al. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107, 2123-2130 (2006).
23. Chatterjee, B. E. et al. Annexin 1 deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J. Leukoc. Biol. 78, 639-646 (2005).
24. Mancuso, F., Flower, R. J. & Perretti, M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J. Immunol. 155, 377-386 (1995).
25. + T cells. Arthritis Res. Ther. 7, R291-R301 (2005).
26. Yang, Y. H. et al. Modulation of inflammation and response to dexamethasone by annexin-1 in antigen-induced arthritis. Arthritis Rheum. 50, 976-984 (2004).
27. Ohshima, S. et al. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl Acad. Sci. USA 95, 8222-8226 (1998).
28. Yang, Y. H. et al. Annexin 1 negatively regulates IL-6 expression via effects on p38 MAPK and MAPK phosphatase-1. J. Immunol. 177, 8148-8153 (2006).
29. Damazo, A. S. et al. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am. J. Pathol. 166, 1607-1617 (2005).
30. 4 receptor. Nature Med. 8, 1296-1302 (2002).
31. Chiang, N. et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487 (2006).
32. Babbin, B. A. et al. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J. Biol. Chem. 281, 19588-19599 (2006).
33. He, R., Sang, H. & Ye, R. D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101, 1572-1581 (2003).
34. 4 receptor. Blood 95, 1810-1818 (2000).
35. Solito, E. et al. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17, 1544-1546 (2003).
36. Gao, J.-L., Chen, H., Filie, J. D., Kozak, C. A. & Murphy, P. M. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51, 270-276 (1998).
37. Perretti, M., Getting, S. J., Solito, E., Murphy, P. M. & Gao, J. L. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am. J. Pathol. 158, 1969-1973 (2001).
38. Gavins, F. N., Yona, S., Kamal, A. M., Flower, R. J. & Perretti, M. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101, 4140-4147 (2003).
39. Souza, D. G. et al. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J. Immunol. 179, 8533-8543 (2007).
40. Ferlazzo, V. et al. Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. Int. Immunopharmacol. 3, 1363-1369 (2003).
41. Clark, A. R. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell. Endocrinol. 275, 79-97 (2007).
42. Goulding, N. J. et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 335, 1416-1418 (1990).
43. Solito, E., de Coupade, C., Parente, L., Flower, R. J. & Russo-Marie, F. IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine 10, 514-521 (1998).
44. -/- mouse. FASEB J. 17, 253-255 (2003).
45. Damazo, A. S., Yona, S., Flower, R. J., Perretti, M. & Oliani, S. M. Spatial and temporal profiles for antiinflammatory gene expression in leukocytes during a resolving model of peritonitis. J. Immunol. 176, 4410-4418 (2006).
46. Sawmynaden, P. & Perretti, M. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. Biochem. Biophys. Res. Commun. 349, 1351-1355 (2006).
47. Ehrchen, J. et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109, 1265-1274 (2007).
48. 4 receptor (ALX) up-regulation. Biomed. Pharmacother. 61, 81-85 (2007).
49. Croxtall, J. D., van Hal, P. T., Choudhury, Q., Gilroy, D. W. & Flower, R. J. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br. J. Pharmacol. 135, 511-519 (2002).
50. Franchimont, D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann. NY Acad. Sci. 1024, 124-137 (2004).
51. Van Laethem, F. et al. Glucocorticoids attenuate T cell receptor signaling. J. Exp. Med. 193, 803-814 (2001).
52. Van Laethem, F., Baus, E., Andris, F., Urbain, J. & Leo, O. A novel aspect of the anti-inflammatory actions of glucocorticoids: inhibition of proximal steps of signaling cascades in lymphocytes. Cell. Mol. Life Sci. 58, 1599-1606 (2001).
53. Adcock, I. M. Glucocorticoid-regulated transcription factors. Pulm. Pharmacol. Ther. 14, 211-219 (2001).
54. + T cells in vitro. J. Immunol. 156, 2406-2412 (1996).
55. Ramirez, F. Glucocorticoids induce a Th2 response in vitro. Dev. Immunol. 6, 233-243 (1998).
56. Elenkov, I. J. Glucocorticoids and the Th1/Th2 balance. Ann. NY Acad. Sci. 1024, 138-146 (2004).
57. + T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur. J. Immunol. 30, 2344-2354 (2000).
58. D'Acquisto, F. et al. Annexin-1 modulates T-cell activation and differentiation. Blood 109, 1095-1102 (2007).
59. D'Acquisto, F. et al. Impaired T cell activation and increased Th2 lineage commitment in annexin-1-deficient T cells. Eur. J. Immunol. 37, 3131-3142 (2007).
60. Ebisuya, M., Kondoh, K. & Nishida, E. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell Sci. 118, 2997-3002 (2005).
61. Boyton, R. J. & Altmann, D. M. Is selection for TCR affinity a factor in cytokine polarization? Trends Immunol. 23, 526-529 (2002).
62. Marti, F., Lapinski, P. E. & King, P. D. The emerging role of the T cell-specific adaptor (TSAd) protein as an autoimmune disease-regulator in mouse and man. Immunol. Lett. 97, 165-170 (2005).
63. Tagoe, C. E. et al. Annexin-1 mediates TNF-α-stimulated matrix metalloproteinase secretion from rheumatoid arthritis synovial fibroblasts. J. Immunol. 181, 2813-2820 (2008).
64. + T cells. Rheumatology (Oxford) 47, 636-639 (2008).
65. Caramori, G. et al. Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies. Eur. Respir. J. 18, 466-473 (2001).
66. Zhou, M. & Ouyang, W. The function role of GATA-3 in Th1 and Th2 differentiation. Immunol. Res. 28, 25-37 (2003).
67. Jee, Y. K. et al. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J. Biol. Chem. 280, 23243-23250 (2005).
68. Barrionuevo, P. et al. A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J. Immunol. 178, 436-445 (2007).
69. Anderson, A. C. et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318, 1141-1143 (2007).
70. Ito, K. et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J. Exp. Med. 203, 7-13 (2006).
71. Song, I. H. & Buttgereit, F. Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol. Cell. Endocrinol. 246, 142-146 (2006).
72. Lowenberg, M. et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep. 7, 1023-1029 (2006).
73. Moraes, L. A. et al. Ligand-specific glucocorticoid receptor activation in human platelets. Blood 106, 4167-4175 (2005).
74. Badolato, R. et al. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 155, 4004-4010 (1995).
75. Le, Y. et al. Amyloid β42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123 (2001).
76. Fu, H. et al. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79, 247-256 (2006).
77. Le, Y. et al. Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J. 272, 769-778 (2005).
78. Rodrigues-Lisoni, F. C. et al. In vitro and in vivo studies on CCR10 regulation by annexin A1. FEBS Lett. 580, 1431-1438 (2006).
79. Lange, C., Starrett, D., Goetsch, J., Gerke, V. & Rescher, U. Transcriptional profiling of human monocytes reveals complex changes in the expression pattern of inflammation-related genes in response to the annexin A1-derived peptide Ac1-25. J. Leukoc. Biol. 82, 1592-1604 (2007).
80. Burli, R. W. et al. Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorg. Med. Chem. Lett. 16, 3713-3718 (2006).
81. Gilmour, J. S. et al. Local amplification of glucocorticoids by 11 β-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes. J. Immunol. 176, 7605-7611 (2006).
82. Liu, Y. et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639-3646 (1999).
83. Scannell, M. et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J. Immunol. 178, 4595-4605 (2007).
84. Maderna, P., Yona, S., Perretti, M. & Godson, C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2-26. J. Immunol. 174, 3727-3733 (2005).